- Home
- CHRS vs IMPP Comparison
CHRS vs IMPP Comparison
Compare CHRS & IMPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- IMPP
- Stock Information
- Founded
- CHRS 2010
- IMPP 1981
- Country
- CHRS United States
- IMPP Greece
- Employees
- CHRS N/A
- IMPP N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- IMPP Marine Transportation
- Sector
- CHRS Health Care
- IMPP Consumer Discretionary
- Exchange
- CHRS Nasdaq
- IMPP Nasdaq
- Market Cap
- CHRS 194.1M
- IMPP 174.2M
- IPO Year
- CHRS 2014
- IMPP N/A
- Fundamental
- Price
- CHRS $1.69
- IMPP $4.33
- Analyst Decision
- CHRS Strong Buy
- IMPP Strong Buy
- Analyst Count
- CHRS 4
- IMPP 1
- Target Price
- CHRS $4.51
- IMPP $5.50
- AVG Volume (30 Days)
- CHRS 1.4M
- IMPP 409.9K
- Earning Date
- CHRS 11-05-2025
- IMPP 12-01-2025
- Dividend Yield
- CHRS N/A
- IMPP N/A
- EPS Growth
- CHRS N/A
- IMPP N/A
- EPS
- CHRS 1.55
- IMPP 1.02
- Revenue
- CHRS $272,209,000.00
- IMPP $127,675,263.00
- Revenue This Year
- CHRS N/A
- IMPP $9.69
- Revenue Next Year
- CHRS $109.48
- IMPP $51.33
- P/E Ratio
- CHRS $3.27
- IMPP $4.30
- Revenue Growth
- CHRS 52.33
- IMPP N/A
- 52 Week Low
- CHRS $0.66
- IMPP $2.12
- 52 Week High
- CHRS $2.43
- IMPP $5.25
- Technical
- Relative Strength Index (RSI)
- CHRS 62.59
- IMPP 47.75
- Support Level
- CHRS $1.63
- IMPP $4.55
- Resistance Level
- CHRS $1.89
- IMPP $4.90
- Average True Range (ATR)
- CHRS 0.12
- IMPP 0.30
- MACD
- CHRS 0.00
- IMPP -0.09
- Stochastic Oscillator
- CHRS 64.42
- IMPP 5.43
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.